Nutrition and aging. The Carla workshop

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Haveman-Nies A, de Groot LP, Burema J, Cruz JA et al. Dietary quality and lifestyle factors in relation to 10-year mortality in older Europeans: the SENECA study. Am J Epidemiol 2002;156(10): 962–8

    PubMed  Google Scholar 

  2. 2.

    Knoops KT, de Groot LC, Kromhout D et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004;292(12): 1433–9

    PubMed  Google Scholar 

  3. 3.

    Van der Wielen RP, Löwik MR, van den Berg H et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995;346: 207–210

    PubMed  Google Scholar 

  4. 4.

    Prentice A. Diet, nutrition and the prevention of osteoporosis. Public Health Nutr 2004;7: 227–243

    PubMed  CAS  Google Scholar 

  5. 5.

    Boonen S, Vanderschueren D, Haentjens P, and Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis — a clinical update. J Intern Med 2006; 259(6): 539–552

    PubMed  CAS  Google Scholar 

  6. 6.

    Luchsinger JA, Mayeux R. Dietary factors and Alzheimer’s disease. Lancet Neurol 2004;3(10): 579–587

    PubMed  Google Scholar 

  7. 7.

    Gillette Guyonnet S, Abellan Van Kan G, Andrieu S et al. IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 2007; 11(2): 132–152

    Google Scholar 

  8. 8.

    Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ 2005;330: 524–526

    PubMed  CAS  Google Scholar 

  9. 9.

    Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293(18): 2257–2264

    PubMed  CAS  Google Scholar 

  10. 10.

    Boonen S, Crepaldi G. Reducing fracture risk in the oldest old: aging and the effect of pharmaceutical interventions in osteoporosis. Aging Clin Exp Res 2007; 19(1): 1–3

    PubMed  CAS  Google Scholar 

  11. 11.

    Cranney A, Horsley T, O’Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess 2007;(158): 1–235

  12. 12.

    van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350(20): 2033–2041

    PubMed  Google Scholar 

  13. 13.

    McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004; 350(20): 2042–2049

    PubMed  CAS  Google Scholar 

  14. 14.

    Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, et al. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 2005;20(6): 921–929

    PubMed  CAS  Google Scholar 

  15. 15.

    Sato Y, Honda Y, Iwamoto J, et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005; 293(9): 1082–1088

    PubMed  CAS  Google Scholar 

  16. 16.

    Raman G, Tatsioni A, Chung M, et al. Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function. J Nutr 2007; 137(7): 1789–1794

    PubMed  CAS  Google Scholar 

  17. 17.

    Eussen SJ, de Groot LC, Joosten LW, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr 2006;84(2): 361–370

    PubMed  CAS  Google Scholar 

  18. 18.

    Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007;369(9557): 208–216

    PubMed  CAS  Google Scholar 

  19. 19.

    Morley JE. Orexigenic and anabolic agents. Clin Geriatr Med 2002; 18(4): 853–866

    PubMed  Google Scholar 

  20. 20.

    Morley JE. Pathophysiology of anorexia. Clin Geriatr Med 2002; 18(4): 661–673

    PubMed  Google Scholar 

  21. 21.

    Roberts SB, Fuss P, Heyman MB, et al. Control of food intake in older men. JAMA 1994; 272(20): 1601–1606

    PubMed  CAS  Google Scholar 

  22. 22.

    Dangour AD, Uauy R. Nutrition challenges for the twenty-first century. Br J Nutr 2006; 96 Suppl 1: S2–7

    PubMed  CAS  Google Scholar 

  23. 23.

    Vellas B, Andrieu S, Sampaio C, Wilcock G. Disease-modifying trials in Alzheimer’s disease: a European task force consensus. Lancet Neurol. 2007;6(1): 56–62

    PubMed  Google Scholar 

  24. 24.

    Fried LP, Tangen CM, Walston J, Newman AB, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3): 146–156

    Google Scholar 

  25. 25.

    Roubenoff R. Sarcopenia: effects on body composition and function. J Gerontol A Biol Sci Med Sci 2003;58(11): 1012–1017

    PubMed  Google Scholar 

  26. 26.

    Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J Appl Physiol. 2000 Jul;89(1): 81–8

    PubMed  CAS  Google Scholar 

  27. 27.

    Frontera WR, Hughes VA, Fielding RA, et al. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol. 2000;88(4): 1321–1326

    PubMed  CAS  Google Scholar 

  28. 28.

    Greig CA, Botella J, Young A. The quadriceps strength of healthy elderly people remeasured after eight years. Muscle Nerve 1993;16(1): 6–10

    PubMed  CAS  Google Scholar 

  29. 29.

    Morley JE, Baumgartner RN, Roubenoff R, et al. Sarcopenia. J Lab Clin Med 2001;137(4): 231–243

    PubMed  CAS  Google Scholar 

  30. 30.

    Newman AB, Kupelian V, Visser M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 2003; 51(11): 1602–1609

    PubMed  Google Scholar 

  31. 31.

    Janssen I, Baumgartner RN, Ross R, et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159(4): 413–421

    PubMed  Google Scholar 

  32. 32.

    Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147(8): 755–763

    PubMed  CAS  Google Scholar 

  33. 33.

    Short KR, Nair KS. The effect of age on protein metabolism. Curr Opin Clin Nutr Metab Care. 2000;3(1): 39–44

    PubMed  CAS  Google Scholar 

  34. 34.

    Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci 2000;904: 437–448

    PubMed  CAS  Article  Google Scholar 

  35. 35.

    Blaum CS, Xue QL, Michelon E, et al. The association between obesity and the frailty syndrome in older women: the Women’s Health and Aging Studies. J Am Geriatr Soc 2005;53(6): 927–934

    PubMed  Google Scholar 

  36. 36.

    Villareal DT, Banks M, Sinacore DR, Siener C, Klein S. Effect of weight loss and exercise on frailty in obese older adults. Arch Intern Med 2006; 166(8): 860–866

    PubMed  Google Scholar 

  37. 37.

    World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR, 2007

    Google Scholar 

  38. 38.

    Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hoffmann A, Witteman JC et al. Diet and risk of dementia: Does fat matter? Neurology 2002; 59: 1915–1921

    PubMed  CAS  Article  Google Scholar 

  39. 39.

    Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals of Neurology 1997b; 42(5): 776–782

    PubMed  CAS  Google Scholar 

  40. 40.

    Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 2004; 62: 1573–1579

    PubMed  CAS  Google Scholar 

  41. 41.

    Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer’s disease. Arch Neurol 2003; 60: 194–200

    PubMed  Google Scholar 

  42. 42.

    Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ 2002; 325(7370): 932–933

    PubMed  Google Scholar 

  43. 43.

    Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005; 62(12): 1849–1853

    PubMed  Google Scholar 

  44. 44.

    Corrada MM, Kawas CH, Hallfrisch J, Muller D, Brookmeyer R. Reduced risk of Alzheimer’s disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimer’s &Dementia 2005;11–18

  45. 45.

    Morris MC, Evans DA, Schneider JA, Tangney CC, Bienias, JL, Aggarwal NT. Dietary folate and vitamins B12 and B6 not associated with incident Alzheimer’s disease. Journal of Alzheimer’s Disease 2006;435–443

  46. 46.

    Seshadri S, Beiser A, Selhub J, Jacques PF et al. Plasma homocysteine as a risk factor dementia and Alzheimer’s disease. NEJM. 2002;346: 476–483

    PubMed  CAS  Google Scholar 

  47. 47.

    Ravaglia G, Forti P, Maioli F et al. Homocysteine and folate as risk factors for dementia and Alzheimer’s disease. Am J Clin Nutr. 2005;82: 636–643

    PubMed  CAS  Google Scholar 

  48. 48.

    Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer’s disease. Neurology. 2001;56(9): 1188–1194

    PubMed  CAS  Google Scholar 

  49. 49.

    Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology. 2004;62(11): 1972–1976

    PubMed  CAS  Google Scholar 

  50. 50.

    Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS, Aggarwal NT et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr. 2005; 81(2): 508–514

    PubMed  CAS  Google Scholar 

  51. 51.

    Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Vitamin E and Cognitive Decline. Arch Neurol. 2002; 59: 1125–1132

    PubMed  Google Scholar 

  52. 52.

    Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002; 287, 24: 3223–3229

    PubMed  CAS  Google Scholar 

  53. 53.

    Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer’s disease in a biracial community study. JAMA. 2002; 287: 3230–3237

    PubMed  CAS  Google Scholar 

  54. 54.

    Commenges D, Scotet V, Renuad S, et al. Intake of flavinoids and risk of dementia. Eur J Epidemiol. 2000; 16: 357–363

    PubMed  CAS  Google Scholar 

  55. 55.

    Laurin D, Masaki KH, Foley DJ, White LR, Launer LJ. Midlife dietary intake of antioxidants and risk of late-life incident dementia. The Honolulu-Asia Aging Study. Am J Epidemiol. 2004; 159: 959–967

    PubMed  Google Scholar 

  56. 56.

    Luchsinger JA, Tang MX, Shea S., Mayeux R. Antioxidant vitamin intake and risk of Alzheimer’s disease. Arch Neurol. 2003;60: 203–208

    PubMed  Google Scholar 

  57. 57.

    Maxwell CJ, Hicks MS, Hogan DB, Basran J, Ebly EM. Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia. Dement Geriatr Cogn Disor. 2005;20: 45–51

    CAS  Google Scholar 

  58. 58.

    Masaki KH, Losonczy KG, Ismirlian G et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology. 2000;54: 1265–1272

    PubMed  CAS  Google Scholar 

  59. 59.

    Grodstein F, Chen J, Willett WC. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr. 2003;77: 975–984

    PubMed  CAS  Google Scholar 

  60. 60.

    Gray SL, Hanlon JT, Landerman LR, Artz M, Schmader KE, Fillenbaum GG. Is antioxydant use protective of cognitive function in the community-dwelling elderly? Am J Geriatr Pharmacother. 2003; 1: 3–10

    PubMed  CAS  Google Scholar 

  61. 61.

    Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol. 2004;61, 1: 82–88

    PubMed  Google Scholar 

  62. 62.

    Elmstahl S, Persson M, Andren M, Blabolil V. Malnutrition in geriatric patients: a neglected problem? J Adv Nurs. 1997; 26(5): 851–855

    PubMed  CAS  Google Scholar 

  63. 63.

    Sempos CT, Johnson NE, Elmer PJ, Allington JK, Matthews ME. A dietary survey of 14 Wisconsin nursing homes. J Am Diet Assoc. 1982;81(1): 35–40

    PubMed  CAS  Google Scholar 

  64. 64.

    Suominen N et al. Malnutrition and associated factors among aged residents in all nursing homes in Helsinki. Eur J Clin Nutr. 2005;59(4): 578–583

    PubMed  CAS  Google Scholar 

  65. 65.

    Zuliani G, Romagnoni F, Volpato S, et al. Nutritional parameters, body composition, and progression of disability in older disabled residents living in nursing homes. J Gerontol A Biol Sci Med Sci. 2001;56(4): 212–216

    Google Scholar 

  66. 66.

    Amelia EJ. Mealtime difficulties. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 66–82.

    Google Scholar 

  67. 67.

    Blaum CS, Fries BE, Fiatarone MA. Factors associated with low body mass index and weight loss in nursing home residents. J Gerontol A Biol Sci Med Sci. 1995;50(3): 162–168

    Google Scholar 

  68. 68.

    Corbett CF, Crogan NL, Short RA. Using the minimum data set to predict weight loss in nursing home residents. Appl Nurs Res. 2002; 15(4): 249–253

    PubMed  Google Scholar 

  69. 69.

    Persson M, Elmstahl S, Blabolil V. The reproducibility of a new dietary record routine in geriatric patients. Clin Nutr. 2002;21: 15–25

    PubMed  CAS  Google Scholar 

  70. 70.

    Vellas B, Villars H, Abellan G, Soto ME, et al. Overview of the MNA-Its history and challenges. J Nutr Health Aging. 2006; 10(6): 456–463

    PubMed  CAS  Google Scholar 

  71. 71.

    Milne AC, Potter J, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev. 2005; 18(2): CD003288

    Google Scholar 

  72. 72.

    Koretz RL, Avenell A, Lipman TO, Braunschweig CL, Milne AC. Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am J Gastroenterol 2007;102(2): 412–429

    PubMed  Google Scholar 

  73. 73.

    Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R. Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy. Eur J Cancer 1997;33(1): 75–79

    PubMed  CAS  Google Scholar 

  74. 74.

    Reuben DB, Hirsch SH, Zhon K, Greendale GA. The Effects of Megestrol Acetate Suspension for Elderly Patients with Reduced Appetite After Hospitalization: A Phase II Randomized Clinical Trial. J Am Geriatr Soc. 2005;53(6): 970–975

    PubMed  Google Scholar 

  75. 75.

    Simmons SF, Walker KA, Osterweil D. The effect of megestrol acetate on oral food and fluid intake in nursing home residents: a pilot study. Am Med Dir Assoc. 2005;6(3 Suppl): S5-S11

    Google Scholar 

  76. 76.

    World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. 1994. Report of a WHO study group. WHO Technical Report Series; No 843

  77. 77.

    Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992;2: 285–289

    PubMed  CAS  Google Scholar 

  78. 78.

    Compston & Rosen: Fast Facts: Osteoporosis, Health Press 2006

  79. 79.

    Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002; 288(3): 321–333

    PubMed  CAS  Google Scholar 

  80. 80.

    Udell JA, Fischer MA, Brookhart MA, Solomon DH, Choudhry NK. Effect of the Women’s Health Initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res. 2006;21(5): 765–771

    PubMed  Google Scholar 

  81. 81.

    De Laet C, Kanis JA, Odén A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005; 16(11): 1330–1338

    PubMed  Google Scholar 

  82. 82.

    Delmi, Rapin, Bengoa, Delmas, Vasey, Bonjour. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet. 1990; 337: 1013–1016

    Google Scholar 

  83. 83.

    Tkatch, Rapin, Rizzoli, Slosman, Nydegger, Vasey, Bonjour. Benefits of oral protein supplementation with fracture of the proximal femur. J Am Col. Nutr. 1992; 11: 519–525

    CAS  Google Scholar 

  84. 84.

    Geinoz, Rapin, Rizzoli, Kraemer, Buchs, Slosman, Michel, Bonjour. Relationship between bone mineral density and dietary intakes in the elderly. Osteoporos Int. 1993: 242–248

  85. 85.

    Schürch MA, Rizzoli R, Slosman D, et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;128(10): 801–809

    PubMed  Google Scholar 

  86. 86.

    Hannan MT, Tucker KL, Dawson-Hughes B, Cupples LA, Felson DT, Kiel DP. Effect of dietary protein on bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 2000; 15: 2504–2512

    PubMed  CAS  Google Scholar 

  87. 87.

    Munger RG, Cerhan JR, Chiu BC. Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women. Am J Clin Nutr 1999;69: 147–152

    PubMed  CAS  Google Scholar 

  88. 88.

    Kerstetter JE, O’Brien KO, Insogna KL. Dietary protein, calcium metabolism, and skeletal homeostasis revisited. Am J Clin Nutr. 2003;78: 584S-592S

    PubMed  CAS  Google Scholar 

  89. 89.

    Bonjour JP. Dietary protein: an essential nutrient for bone health. J Am Coll Nutr. 2005;24: 526S-36S

    PubMed  CAS  Google Scholar 

  90. 90.

    Kyle UG, Genton L, Slosman DO, Pichard C. Fat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 years. Nutrition. 2001; 17(7-8): 534–541

    PubMed  CAS  Google Scholar 

  91. 91.

    Kyle UG, Genton L, Pichard C. Body composition: what’s new? Curr Opin Clin Nutr Metab Care. 2002;5(4): 427–433

    PubMed  Google Scholar 

  92. 92.

    Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002; 162(18): 2074–2079

    PubMed  Google Scholar 

  93. 93.

    Visser M, Langlois J, Guralnik JM, Cauley JA, Kronmal RA, Robbins J, Williamson JD, Harris TB. High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr. 1998; 68(3): 584–590

    PubMed  CAS  Google Scholar 

  94. 94.

    Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004; 12(12): 1995–2004

    PubMed  Google Scholar 

  95. 95.

    Houston DK, Stevens J, Cai J. Abdominal fat distribution and functional limitations and disability in a biracial cohort: the Atherosclerosis Risk in Communities Study. Int J Obes (Lond). 2005;29(12): 1457–1463

    CAS  Google Scholar 

  96. 96.

    Villareal DT, Banks M, Sinacore DR, Siener C, Klein S. Effect of weight loss and exercise on frailty in obese older adults. Arch Intern Med. 2006; 166(8): 860–866

    PubMed  Google Scholar 

  97. 97.

    Ensrud KE, Ewing SK, Stone KL, et al. Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women. J Am Geriatr Soc. 2003;51(12): 1740–1747

    PubMed  Google Scholar 

  98. 98.

    Newman AB, Yanez D, Harris T, et al. Weight change in old age and its association with mortality. J Am Geriatr Soc. 2001;49(10): 1309–1318

    PubMed  CAS  Google Scholar 

  99. 99.

    Cederholm T, Jägrén C, Hellström K. Outcome of protein-energy malnutrition in elderly medical patients. Am J Med. 1995;98(1): 67–74

    PubMed  CAS  Google Scholar 

  100. 100.

    Roubenoff R, Heymsfield SB, Kehayias JJ, Cannon JG, Rosenberg IH. Standardization of nomenclature of body composition in weight loss. Am J Clin Nutr. 1997;66(1): 192–196

    PubMed  CAS  Google Scholar 

  101. 101.

    Thomas DR. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr. 2007;26(4): 389–399

    PubMed  Google Scholar 

  102. 102.

    Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003;52(10): 1479–1486

    PubMed  CAS  Google Scholar 

  103. 103.

    Freund-Levi Y, Eriksdorter-Jönhagen M, Cederholm T, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. ArchNeurol. 2006;63(10): 1402–1408

    Google Scholar 

  104. 104.

    Fiatarone MA, O’Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330(25): 1769–1775

    PubMed  CAS  Google Scholar 

  105. 105.

    Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev. 2005;(2):CD004310

  106. 106.

    Evans WJ. Editorial: Megestrol acetate use for weight gain should be carefully considered. J Clin Endocrinol Metab. 2007;92(2): 420–421

    PubMed  CAS  Google Scholar 

  107. 107.

    Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361(9363): 1077–1083

    PubMed  CAS  Google Scholar 

  108. 108.

    Andersson P, Cederholm T, Johansson AS, Palmblad J. Captopril-impaired production of tumor necrosis factor-alpha-induced interleukin-1beta in human monocytes is associated with altered intracellular distribution of nuclear factorkappaB. J Lab Clin Med. 2002; 140(2): 103–109

    PubMed  CAS  Google Scholar 

  109. 109.

    Cesari M, Leeuwenburgh C, Lauretani F, et al. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am J Clin Nutr. 2006;83(5): 1142–1148

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to G. Abellan van Kan.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

van Kan, G.A., Gambassi, G., de Groot, L.C.P.G.M. et al. Nutrition and aging. The Carla workshop. J Nutr Health Aging 12, 355–364 (2008). https://doi.org/10.1007/BF02982667

Download citation

Keywords

  • Fracture Risk
  • Homocysteine
  • Cognitive Decline
  • Strontium Ranelate
  • Frailty Syndrome